Mometasone Furoate
Loading...Mometasone Furoate Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no warning information available for this product. We apologize for any inconvenience.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Mometasone furoate cream USP, 0.1% is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 2 years of age or older.
History
There is currently no drug history available for this drug.
Other Information
Mometasone furoate cream USP, 0.1% contains mometasone furoate USP for topical use. Mometasone furoate USP is a synthetic corticosteroid with anti-inflammatory activity.
Chemically, mometasone furoate USP is 9α,21-dichloro-11β,17-dihydroxy-16α-methylpregna-1,4-diene-3,20-dione 17-(2-furoate), with the empirical formula C27H30CI2O6, a molecular weight of 521.43 and the following structural formula:
Mometasone furoate USP is a white to off-white powder, soluble in acetone and methylene chloride.
Each gram of mometasone furoate cream USP, 0.1% contains: 1 mg mometasone furoate USP in a cream base of hexylene glycol, phosphoric acid, propylene glycol stearate (55% monoester), stearyl alcohol and ceteareth-20, titanium dioxide, aluminum starch octenylsuccinate (Gamma Irradiated), white wax, white petrolatum, and purified water.
Sources
Mometasone Furoate Manufacturers
-
Proficient Rx Lp
![Mometasone Furoate Cream [Proficient Rx Lp]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Mometasone Furoate | Proficient Rx Lp
Apply a thin film of mometasone furoate cream USP, 0.1% to the affected skin areas once daily. Mometasone furoate cream USP, 0.1% may be used in pediatric patients 2 years of age or older. Since safety and efficacy of mometasone furoate cream USP, 0.1% have not been established in pediatric patients below 2 years of age; use in this age group is not recommended [see Warnings and Precautions (5.1) and Use in Specific Populations (8.4)].
Therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Safety and efficacy of mometasone furoate cream USP, 0.1% in pediatric patients for more than 3 weeks of use have not been established.
Mometasone furoate cream USP, 0.1% should not be used with occlusive dressings unless directed by a physician. Mometasone furoate cream USP, 0.1% should not be applied in the diaper area if the child still requires diapers or plastic pants, as these garments may constitute occlusive dressing.
Mometasone furoate cream USP, 0.1% is for topical use only. It is not for oral, ophthalmic, or intravaginal use.
Avoid use on the face, groin, or axillae.
-
Proficient Rx Lp
Mometasone Furoate | Proficient Rx Lp
Apply a thin film of mometasone furoate cream USP, 0.1% to the affected skin areas once daily. Mometasone furoate cream USP, 0.1% may be used in pediatric patients 2 years of age or older. Since safety and efficacy of mometasone furoate cream USP, 0.1% have not been established in pediatric patients below 2 years of age; use in this age group is not recommended [see Warnings and Precautions (5.1) and Use in Specific Populations (8.4)].
Therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Safety and efficacy of mometasone furoate cream USP, 0.1% in pediatric patients for more than 3 weeks of use have not been established.
Mometasone furoate cream USP, 0.1% should not be used with occlusive dressings unless directed by a physician. Mometasone furoate cream USP, 0.1% should not be applied in the diaper area if the child still requires diapers or plastic pants, as these garments may constitute occlusive dressing.
Mometasone furoate cream USP, 0.1% is for topical use only. It is not for oral, ophthalmic, or intravaginal use.
Avoid use on the face, groin, or axillae.
-
Proficient Rx Lp
Mometasone Furoate | Proficient Rx Lp
Apply a thin film of Mometasone Furoate Cream USP, 0.1% to the affected skin areas once daily. Mometasone furoate cream may be used in pediatric patients 2 years of age or older. Since safety and efficacy of mometasone furoate cream have not been established in pediatric patients below 2 years of age; use in this age group is not recommended [see Warnings and Precautions (5.1) and Use in Specific Populations (8.4)].
Therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Safety and efficacy of mometasone furoate cream in pediatric patients for more than 3 weeks of use have not been established.
Mometasone furoate cream should not be used with occlusive dressings unless directed by a physician. Mometasone furoate cream should not be applied in the diaper area if the child still requires diapers or plastic pants, as these garments may constitute occlusive dressing.
Mometasone furoate cream is for topical use only. It is not for oral, ophthalmic, or intravaginal use.
Avoid use on the face, groin, or axillae.
-
Sandoz
Mometasone Furoate | Sandoz
Apply a thin film of Mometasone Furoate Cream USP, 0.1% to the affected skin areas once daily. Mometasone Furoate Cream USP, 0.1% may be used in pediatric patients 2 years of age or older. Since safety and efficacy of Mometasone Furoate Cream USP, 0.1% have not been adequately established in pediatric patients below 2 years of age, its use in this age group is not recommended. (See PRECAUTIONS - Pediatric Use section.)
As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Safety and efficacy of Mometasone Furoate Cream USP, 0.1% in pediatric patients for more than 3 weeks of use have not been established.
Mometasone Furoate Cream USP, 0.1% should not be used with occlusive dressings unless directed by a physician. Mometasone Furoate Cream USP, 0.1% should not be applied in the diaper area if the child still requires diapers or plastic pants, as these garments may constitute occlusive dressing.
-
Physicians Total Care, Inc.
Mometasone Furoate | Physicians Total Care, Inc.
Apply a thin film of mometasone furoate cream USP 0.1% to the affected skin areas once daily. Mometasone furoate cream USP 0.1% may be used in pediatric patients 2 years of age or older. Since safety and efficacy of mometasone furoate cream USP 0.1% have not been adequately established in pediatric patients below 2 years of age, its use in this age group is not recommended (see PRECAUTIONS: Pediatric Use: section).
As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Safety and efficacy of mometasone furoate cream USP 0.1% in pediatric patients for more than 3 weeks of use have not been established.
Mometasone furoate cream USP 0.1% should not be used with occlusive dressings unless directed by a physician. Mometasone furoate cream USP 0.1 % should not be applied in the diaper area if the child still requires diapers or plastic pants as these garments may constitute occlusive dressing.
-
Stat Rx Usa Llc
Mometasone Furoate | Stat Rx Usa Llc
Apply a thin film of Mometasone Furoate Cream 0.1% to the affected skin areas once daily. Mometasone Furoate Cream 0.1% may be used in pediatric patients 2 years of age or older. Since safety and efficacy of Mometasone Furoate Cream 0.1% have not been adequately established in pediatric patients below 2 years of age, its use in this age group is not recommended (see PRECAUTIONS – Pediatric Use section).
As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Safety and efficacy of Mometasone Furoate Cream 0.1% in pediatric patients for more than 3 weeks of use have not been established. Mometasone Furoate Cream 0.1% should not be used with occlusive dressings unless directed by a physician. Mometasone Furoate Cream 0.1% should not be applied in the diaper area if the child still requires diapers or plastic pants as these garments may constitute occlusive dressing.
-
Rebel Distributors Corp
Mometasone Furoate | Rebel Distributors Corp
Apply a thin film of Mometasone Furoate Cream 0.1% to the affected skin areas once daily. Mometasone Furoate Cream 0.1% may be used in pediatric patients 2 years of age or older. Since safety and efficacy of Mometasone Furoate Cream 0.1% have not been adequately established in pediatric patients below 2 years of age, its use in this age group is not recommended (see PRECAUTIONS – Pediatric Use section).
As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Safety and efficacy of Mometasone Furoate Cream 0.1% in pediatric patients for more than 3 weeks of use have not been established. Mometasone Furoate Cream 0.1% should not be used with occlusive dressings unless directed by a physician. Mometasone Furoate Cream 0.1% should not be applied in the diaper area if the child still requires diapers or plastic pants as these garments may constitute occlusive dressing.
-
E. Fougera & Co., A Division Of Fougera Pharmaceuticals Inc.
Mometasone Furoate | E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc.
Apply a thin film of mometasone furoate cream USP, 0.1% to the affected skin areas once daily. Mometasone furoate cream USP, 0.1% may be used in pediatric patients 2 years of age or older. Since safety and efficacy of mometasone furoate cream USP, 0.1% have not been established in pediatric patients below 2 years of age; use in this age group is not recommended [see Warnings and Precautions (5.1) and Use in Specific Populations (8.4)].
Therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Safety and efficacy of mometasone furoate cream USP, 0.1% in pediatric patients for more than 3 weeks of use have not been established.
Mometasone furoate cream USP, 0.1% should not be used with occlusive dressings unless directed by a physician. Mometasone furoate cream USP, 0.1% should not be applied in the diaper area if the child still requires diapers or plastic pants, as these garments may constitute occlusive dressing.
Mometasone furoate cream USP, 0.1% is for topical use only. It is not for oral, ophthalmic, or intravaginal use.
Avoid use on the face, groin, or axillae.
-
Taro Pharmaceuticals U.s.a., Inc.
Mometasone Furoate | Taro Pharmaceuticals U.s.a., Inc.
Apply a thin film of Mometasone Furoate Cream USP, 0.1% to the affected skin areas once daily. Mometasone furoate cream may be used in pediatric patients 2 years of age or older. Since safety and efficacy of mometasone furoate cream have not been established in pediatric patients below 2 years of age; use in this age group is not recommended [see Warnings and Precautions (5.1) and Use in Specific Populations (8.4)].
Therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Safety and efficacy of mometasone furoate cream in pediatric patients for more than 3 weeks of use have not been established.
Mometasone furoate cream should not be used with occlusive dressings unless directed by a physician. Mometasone furoate cream should not be applied in the diaper area if the child still requires diapers or plastic pants, as these garments may constitute occlusive dressing.
Mometasone furoate cream is for topical use only. It is not for oral, ophthalmic, or intravaginal use.
Avoid use on the face, groin, or axillae.
-
Global Pharmaceuricals, Division Of Impax Laboratories, Inc.
Mometasone Furoate | Global Pharmaceuricals, Division Of Impax Laboratories, Inc.
Apply a thin film of Mometasone Furoate Cream to the affected skin areas once daily. Mometasone Furoate Cream may be used in pediatric patients 2 years of age or older. Since safety and efficacy of Mometasone Furoate Cream have not been established in pediatric patients below 2 years of age; use in this age group is not recommended [see Warnings and Precautions (5.1) and Use in Specific Populations (8.4)].
Therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Safety and efficacy of Mometasone Furoate Cream in pediatric patients for more than 3 weeks of use have not been established.
Mometasone Furoate Cream should not be used with occlusive dressings unless directed by a physician. Mometasone Furoate Cream should not be applied in the diaper area if the child still requires diapers or plastic pants, as these garments may constitute occlusive dressing.
Mometasone Furoate Cream is for topical use only. It is not for oral, ophthalmic, or intravaginal use.
Avoid use on the face, groin, or axillae.
-
Clinical Solutions Wholesale
Mometasone Furoate | Clinical Solutions Wholesale
Apply a thin film of mometasone furoate cream to the affected skin areas once daily. Mometasone furoate cream may be used in pediatric patients 2 years of age or older. Since safety and efficacy of mometasone furoate cream have not been adequately established in pediatric patients below 2 years of age, its use in this age group is not recommended (see PRECAUTIONS-Pediatric Usesection).
As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Safety and efficacy of mometasone furoate cream in pediatric patients for more than 3 weeks of use have not been established.
Mometasone furoate cream should not be used with occlusive dressings unless directed by a physician. Mometasone furoate cream should not be applied in the diaper area if the child still requires diapers or plastic pants as these garments may constitute occlusive dressing.
-
Glenmark Generics Inc., Usa
Mometasone Furoate | Glenmark Generics Inc., Usa
Apply a thin film of mometasone furoate cream USP, 0.1% to the affected skin areas once daily. Mometasone furoate cream USP, 0.1% may be used in pediatric patients 2 years of age or older. Since safety and efficacy of mometasone furoate cream USP, 0.1% have not been established in pediatric patients below 2 years of age; use in this age group is not recommended [see Warnings and Precautions (5.1) and Use in Specific Populations (8.4)].
Therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Safety and efficacy of mometasone furoate cream USP, 0.1% in pediatric patients for more than 3 weeks of use have not been established.
Mometasone furoate cream USP, 0.1% should not be used with occlusive dressings unless directed by a physician. Mometasone furoate cream USP, 0.1% should not be applied in the diaper area if the child still requires diapers or plastic pants, as these garments may constitute occlusive dressing.
Mometasone furoate cream USP, 0.1% is for topical use only. It is not for oral, ophthalmic, or intravaginal use.
Avoid use on the face, groin, or axillae.
-
Perrigo New York Inc.
Mometasone Furoate | Perrigo New York Inc.
Apply a thin film of Mometasone Furoate Cream USP, 0.1% to the affected skin areas once daily. Mometasone furoate cream may be used in pediatric patients 2 years of age or older. Since safety and efficacy of mometasone furoate cream have not been established in pediatric patients below 2 years of age; use in this age group is not recommended [see Warnings and Precautions (5.1) and Use in Specific Populations (8.4)].
Therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Safety and efficacy of mometasone furoate cream in pediatric patients for more than 3 weeks of use have not been established.
Mometasone furoate cream should not be used with occlusive dressings unless directed by a physician. Mometasone furoate cream should not be applied in the diaper area if the child still requires diapers or plastic pants, as these garments may constitute occlusive dressing.
Mometasone furoate cream is for topical use only. It is not for oral, ophthalmic, or intravaginal use.
Avoid use on the face, groin, or axillae.
-
G&w Laboratories, Inc.
Mometasone Furoate | G&w Laboratories, Inc.
Apply a thin film of Mometasone Furoate Cream 0.1% to the affected skin areas once daily. Mometasone Furoate Cream 0.1% may be used in pediatric patients 2 years of age or older. Since safety and efficacy of Mometasone Furoate Cream 0.1% have not been established in pediatric patients below 2 years of age; use in this age group is not recommended [see Warnings and Precautions (5.1) and Use in Specific Populations (8.4)].
Therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Safety and efficacy of Mometasone Furoate Cream 0.1% in pediatric patients for more than 3 weeks of use have not been established.
Mometasone Furoate Cream 0.1% should not be used with occlusive dressings unless directed by a physician. Mometasone Furoate Cream 0.1% should not be applied in the diaper area if the child still requires diapers or plastic pants, as these garments may constitute occlusive dressing.
Mometasone Furoate Cream 0.1% is for topical use only. It is not for oral, ophthalmic, or intravaginal use.
Avoid use on the face, groin, or axillae. -
G&w Laboratories, Inc.
Mometasone Furoate | G&w Laboratories, Inc.
Apply a thin film of Mometasone Furoate, USP Ointment 0.1% to the affected skin areas once daily.
Therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary.
Safety and efficacy of Mometasone Furoate, USP Ointment 0.1% in pediatric patients for more than 3 weeks of use have not been established [see Warnings and Precautions (5.1) and Use in Specific Populations (8.4)].
Mometasone Furoate, USP Ointment 0.1% should not be used with occlusive dressings unless directed by a physician. Mometasone Furoate, USP Ointment 0.1% should not be applied in the diaper area if the child still requires diapers or plastic pants, as these garments may constitute occlusive dressing.
Mometasone Furoate, USP Ointment 0.1% is for topical use only. It is not for oral, ophthalmic, or intravaginal use.
Avoid use on the face, groin, or axillae. -
Harris Pharmaceutical, Inc.
Mometasone Furoate | Harris Pharmaceutical, Inc.
Apply a thin film of Mometasone Furoate Cream 0.1% to the affected skin areas once daily. Mometasone Furoate Cream 0.1% may be used in pediatric patients 2 years of age or older. Since safety and efficacy of Mometasone Furoate Cream 0.1% have not been established in pediatric patients below 2 years of age; use in this age group is not recommended [see Warnings and Precautions (5.1) and Use in Specific Populations (8.4)].
Therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Safety and efficacy of Mometasone Furoate Cream 0.1% in pediatric patients for more than 3 weeks of use have not been established.Mometasone Furoate Cream 0.1% should not be used with occlusive dressings unless directed by a physician. Mometasone Furoate Cream 0.1% should not be applied in the diaper area if the child still requires diapers or plastic pants, as these garments may constitute occlusive dressing.
Mometasone Furoate Cream 0.1% is for topical use only. It is not for oral, ophthalmic, or intravaginal use.
Avoid use on the face, groin, or axillae. -
Harris Pharmaceutical, Inc.
Mometasone Furoate | Harris Pharmaceutical, Inc.
Apply a thin film of Mometasone Furoate, USP Ointment 0.1% to the affected skin areas once daily.
Therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary.
Safety and efficacy of Mometasone Furoate, USP Ointment 0.1% in pediatric patients for more than 3 weeks of use have not been established [see Warnings and Precautions (5.1) and Use in Specific Populations (8.4)].Mometasone Furoate, USP Ointment 0.1% should not be used with occlusive dressings unless directed by a physician. Mometasone Furoate, USP Ointment 0.1% should not be applied in the diaper area if the child still requires diapers or plastic pants, as these garments may constitute occlusive dressing.
Mometasone Furoate, USP Ointment 0.1% is for topical use only. It is not for oral, ophthalmic, or intravaginal use.
Avoid use on the face, groin, or axillae. -
Harris Pharmaceutical, Inc.
Mometasone Furoate | Harris Pharmaceutical, Inc.
Apply a few drops of Mometasone Furoate Topical Solution USP, 0.1% (Lotion) to the affected skin areas once daily and massage lightly until it disappears.
Therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary [see Warnings and Precautions (5.1) and Use in Specific Populations (8.4)].
Mometasone Furoate Topical Solution, 0.1% (Lotion) should not be used with occlusive dressings unless directed by a physician.
Mometasone Furoate Topical Solution, 0.1% (Lotion) should not be applied in the diaper area if the patient still requires diapers or plastic pants, as these garments may constitute occlusive dressing.
Mometasone Furoate Topical Solution USP, 0.1% (Lotion) is for topical use only. It is not for oral, ophthalmic, or intravaginal use.
Avoid use on the face, groin, or axillae. -
G&w Laboratories, Inc.
Mometasone Furoate | G&w Laboratories, Inc.
Apply a few drops of Mometasone Furoate Topical Solution USP, 0.1% (Lotion) to the affected skin areas once daily and massage lightly until it disappears.
Therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary [see Warnings and Precautions (5.1) and Use in Specific Populations (8.4)].
Mometasone Furoate Topical Solution, 0.1% (Lotion) should not be used with occlusive dressings unless directed by a physician.
Mometasone Furoate Topical Solution, 0.1% (Lotion) should not be applied in the diaper area if the patient still requires diapers or plastic pants, as these garments may constitute occlusive dressing.
Mometasone Furoate Topical Solution USP, 0.1% (Lotion) is for topical use only. It is not for oral, ophthalmic, or intravaginal use.
Avoid use on the face, groin, or axillae.
![Mometasone Furoate Cream [Proficient Rx Lp]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=29149dd1-99db-4b8b-8c49-77c1bcd4c3db&name=a4054a20-9abb-4477-a4ba-f31066848641-03.jpg)
![Mometasone Furoate Cream [Proficient Rx Lp]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=2bf06b19-4ed7-41a3-b6fc-29713c41965c&name=mometasone-02.jpg)
![Mometasone Furoate Cream [Sandoz]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=80cf985b-3e1e-426c-9494-5c9b63eb8d5f&name=46d6974e-figure-01.jpg)
![Mometasone Furoate Cream [Physicians Total Care, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=1d856c43-cf09-4746-99b5-af75fba6d229&name=packagelabel.jpg)
![Mometasone Furoate Cream [Stat Rx Usa Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c337bce8-27e9-48fd-85fa-381d0242a36a&name=MOMETASONEFUROATELABEL993.jpg)
![Mometasone Furoate Cream [Rebel Distributors Corp]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=09182072-d05e-4cd4-93c0-d1c0abd6069d&name=09182072-d05e-4cd4-93c0-d1c0abd6069d-02.jpg)
![Mometasone Furoate Cream [E. Fougera & Co., A Division Of Fougera Pharmaceuticals Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9253f6a9-2cf7-412d-b7a5-d9292d7b97fd&name=91dfbe51-ca93-48c6-b84f-c2220cc7d09e-02.jpg)
![Mometasone Furoate Cream [Taro Pharmaceuticals U.s.a., Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=ce61920d-65df-4423-925d-091e624ea32e&name=mometasone-02.jpg)
![Mometasone Furoate Cream [Global Pharmaceuricals, Division Of Impax Laboratories, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=4063fa4c-879f-41a0-a03d-bf22ddda958c&name=a7e3350d-figure-01.jpg)
![Mometasone Furoate Cream [Clinical Solutions Wholesale]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=691bf68b-9fc8-41d8-b0b7-a41826a718b3&name=691bf68b-9fc8-41d8-b0b7-a41826a718b3-03.jpg)
![Mometasone Furoate Cream [Glenmark Generics Inc., Usa]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=031283ed-988b-4698-8a2e-00f3d41c0f71&name=a4054a20-9abb-4477-a4ba-f31066848641-03.jpg)
![Mometasone Furoate Cream [Perrigo New York Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=a12fef6b-681e-4f80-8bcd-3f01733f1a67&name=mometasone-02.jpg)
![Mometasone Furoate (Mometasone Furoate) Cream [G&w Laboratories, Inc.]](http://recallguide.cwdevelopsp.com/wp-content/themes/recallguide/assets/img/drug-image-placeholder.jpg)
Login To Your Free Account